s6y

3 Kaleido Biosciences, Inc.: Initial statement of beneficial ownership of securities

Filed
Period
Accession number
0000899243-19-005061

Documents

  1. FORM 3 SUBMISSION 3
  2. EX-24.1 DOCUMENT EX-24.1

On sec.gov